|
Originally published In Press as doi:10.1074/jbc.M609717200 on February 19, 2007
J. Biol. Chem., Vol. 282, Issue 15, 10953-10962, April 13, 2007
Evidence for 1,25-Dihydroxyvitamin D3-independent Transactivation by the Vitamin D ReceptorUNCOUPLING THE RECEPTOR AND LIGAND IN KERATINOCYTES*
Tara I. Ellison 1,
Richard L. Eckert , and
Paul N. MacDonald 2
From the
Departments of Pharmacology and Physiology and Biophysics, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106
The vitamin D endocrine system plays critical although poorly understood roles in skin. Vitamin D receptor (VDR) knock-out (VDRKO) mice have defects in hair follicle cycling and keratinocyte proliferation leading to epidermal thickening, dermal cyst formation, and alopecia. Surprisingly, skin defects are not apparent in mice lacking 25-hydroxyvitamin D 1 -hydroxylase, the enzyme required for 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) hormone biosynthesis. These disparate phenotypes indicate that VDR effects in skin are independent of the 1,25(OH)2D3 ligand. However, cellular or molecular data supporting this hypothesis are lacking. Here, we show transcriptional activation of the vitamin D-responsive 24-hydroxylase promoter by VDR in primary keratinocytes that is independent of the 1,25(OH)2D3 ligand. This activity required functional vitamin D-responsive promoter elements as well as an intact VDR DNA binding domain and thus could not be distinguished from 1,25(OH)2D3-dependent VDR transactivation. The 1,25(OH)2D3-independent activation of VDR was also observed in keratinocytes from 1 -hydroxylase knock-out mice, indicating that it is not due to endogenous 1,25(OH)2D3 production. Mammalian two-hybrid studies showed strong, 1,25(OH)2D3-independent interaction between VDR and retinoid X receptors in primary keratinocytes, indicating that enhanced heterodimerization of these receptors was involved. Indeed, this 1,25(OH)2D3-independent VDR-RXR heterodimerization was sufficient to drive transactivation by VDR(L233S), an inactive ligand binding mutant of VDR that was previously shown to rescue the skin phenotype of VDR null mice. Cumulatively, these studies support the concept that transactivation by VDR in keratinocytes may be uncoupled from the 1,25(OH)2D3 ligand.
Received for publication, October 16, 2006
, and in revised form, February 2, 2007.
* This work was supported by National Institutes of Health Grant RO1DK53980 and by a Pilot and Feasibility Component of the Skin Disease Research Center at Case Western Reserve University, P30 AR639750 (to P. N. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Supported by NIGMS, National Institutes of Health, Institutional National Research Service Award T32GM 08803.
2 To whom correspondence should be addressed: Dept. of Pharmacology, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106. Tel.: 216-368-2466; Fax: 216-368-3395; E-mail: pnm2{at}case.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
X. Zhang, D. R. Dowd, M. C. Moore, T. A. Kranenburg, M. A. Meester-Smoor, E. C. Zwarthoff, and P. N. MacDonald
Meningioma 1 Is Required for Appropriate Osteoblast Proliferation, Motility, Differentiation, and Function
J. Biol. Chem.,
July 3, 2009;
284(27):
18174 - 18183.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|